Aurobindo Pharma Secures Regulatory Approval for Bevacizumab Biosimilar in India
Regulatory Milestone for Aurobindo Pharma Aurobindo Pharma’s subsidiary has received formal marketing authorization from the Central Drugs Standard Control Organization (CDSCO) to distribute Bevqolva, a bevacizumab biosimilar, within the Indian market. The approval, granted under Form CT 23, permits the company to market the drug specifically for the treatment of metastatic carcinoma of the colon…